These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. High Epstein-Barr Virus Load and Genomic Diversity Are Associated with Generation of gp350-Specific Neutralizing Antibodies following Acute Infectious Mononucleosis. Weiss ER; Alter G; Ogembo JG; Henderson JL; Tabak B; Bakiş Y; Somasundaran M; Garber M; Selin L; Luzuriaga K J Virol; 2017 Jan; 91(1):. PubMed ID: 27733645 [TBL] [Abstract][Full Text] [Related]
27. Detection of mpox virus in ambient air in a sexual health clinic. Raymenants J; Van Gestel L; Coppens J; De Block T; Bangwen E; Rutgers J; Hens M; De Vos E; Coppens S; Keyaerts E; André E; Rezende AM; Van Esbroeck M; Vercauteren K; Liesenborghs L Arch Virol; 2023 Jul; 168(8):210. PubMed ID: 37486383 [TBL] [Abstract][Full Text] [Related]
28. Survey on neutralizing antibodies against Zika virus eighteen months post-outbreak in two southern Thailand communities. Densathaporn T; Sangthong R; Sakolnapa M; Surasombatpattana S; Kemapunmanus M; Masrinoul P; Yoksan S; McNeil EB; Chongsuvivatwong V BMC Infect Dis; 2020 Dec; 20(1):921. PubMed ID: 33272192 [TBL] [Abstract][Full Text] [Related]
29. Genotype-specific and cross-reactive neutralizing antibodies induced by dengue virus infection: detection of antibodies with different levels of neutralizing activities against homologous and heterologous genotypes of dengue virus type 2 in common marmosets (Callithrix jacchus). Azami NAM; Moi ML; Ami Y; Suzaki Y; Lim CK; Taniguchi S; Saijo M; Takasaki T; Kurane I Virol J; 2018 Mar; 15(1):51. PubMed ID: 29587780 [TBL] [Abstract][Full Text] [Related]
30. Monkeypox: Past, Present, and Future. Khan G; Perveen N Adv Exp Med Biol; 2024; 1451():1-20. PubMed ID: 38801568 [TBL] [Abstract][Full Text] [Related]
31. Human Monkeypox Experience in a Tertiary Level Hospital in Milan, Italy, between May and October 2022: Epidemiological Features and Clinical Characteristics. Candela C; Raccagni AR; Bruzzesi E; Bertoni C; Rizzo A; Gagliardi G; Canetti D; Gianotti N; Mileto D; Gismondo MR; Castagna A; Nozza S; Viruses; 2023 Mar; 15(3):. PubMed ID: 36992376 [TBL] [Abstract][Full Text] [Related]
32. Long-lasting humoral and cellular memory immunity to vaccinia virus Tiantan provides pre-existing immunity against mpox virus in Chinese population. Li M; Guo Y; Deng Y; Gao W; Huang B; Yao W; Zhao Y; Zhang Q; Huang M; Liu M; Li L; Guo P; Tian J; Wang X; Lin Y; Gan J; Guo Y; Hu Y; Zhang J; Yang X; Shang B; Yang M; Han Y; Wang Y; Cong P; Li M; Chu Q; Zhang D; Wang Q; Zhang T; Wu G; Tan W; Gao GF; Liu J Cell Rep; 2024 Jan; 43(1):113609. PubMed ID: 38159277 [TBL] [Abstract][Full Text] [Related]
33. Cross-reactive immune responses to monkeypox virus induced by MVA vaccination in mice. Gao F; He C; Liu M; Yuan P; Tian S; Zheng M; Zhang L; Zhou X; Xu F; Luo J; Li X Virol J; 2023 Jun; 20(1):126. PubMed ID: 37337226 [TBL] [Abstract][Full Text] [Related]
34. Mpox infection protects against re-challenge in rhesus macaques. Aid M; Sciacca M; McMahan K; Hope D; Liu J; Jacob-Dolan C; Powers O; Barrett J; Wu C; Mutoni A; Murdza T; Richter H; Velasco J; Teow E; Boursiquot M; Cook A; Orekov T; Hamilton M; Pessaint L; Ryan A; Hayes T; Martinot AJ; Seaman MS; Lewis MG; Andersen H; Barouch DH Cell; 2023 Oct; 186(21):4652-4661.e13. PubMed ID: 37734373 [TBL] [Abstract][Full Text] [Related]
36. Residual Immunity from Smallpox Vaccination and Possible Protection from Mpox, China. Huang Y; Guo L; Li Y; Ren L; Nie J; Xu F; Huang T; Zhong J; Fan Z; Zhang Y; Xie Y; Zhang Q; Mei S; Xiao Y; Wang X; Xu L; Guo F; Wang J Emerg Infect Dis; 2024 Feb; 30(2):321-324. PubMed ID: 38270156 [TBL] [Abstract][Full Text] [Related]
37. Validation of a new extraction-free real-time PCR test to detect MPOX virus. Lima A; Rowe L; Silbert S Diagn Microbiol Infect Dis; 2024 Jun; 109(2):116265. PubMed ID: 38520832 [TBL] [Abstract][Full Text] [Related]
38. Prevalence of Mpox (Monkeypox) in patients undergoing STI screening in northern California, April-September 2022. Contag CA; Renfro ZT; Lu J; Shen S; Karan A; Solis D; Huang C; Sahoo MK; Yamamoto F; Jones MS; Lin J; Levy V; Pinsky BA J Clin Virol; 2023 Jul; 164():105493. PubMed ID: 37220710 [TBL] [Abstract][Full Text] [Related]
39. Development of an HSV-1 neutralization test with a glycoprotein D specific antibody for measurement of neutralizing antibody titer in human sera. Luo Y; Xiong D; Li HH; Qiu SP; Lin CL; Chen Q; Huang CH; Yuan Q; Zhang J; Xia NS Virol J; 2016 Mar; 13():44. PubMed ID: 26987753 [TBL] [Abstract][Full Text] [Related]
40. Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge. Zeng J; Li Y; Jiang L; Luo L; Wang Y; Wang H; Han X; Zhao J; Gu G; Fang M; Huang Q; Yan J Emerg Microbes Infect; 2023 Dec; 12(1):2204151. PubMed ID: 37070521 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]